Business Wire

  1. Integrated DNA Technologies Expands Into Clinical Diagnostics With First In Vitro Diagnostic 3/23/2026

    Global genomics leader Integrated DNA Technologies (IDT) today announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx in vitro diagnostic (IVD) offerings.

  2. Agilent Showcases Advances In Precision Oncology And Digital Pathology At USCAP 2026 3/19/2026

    Agilent Technologies Inc. today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas.

  3. Ibex Expands U.S. Footprint With HNL Lab Medicine Partnership To Deploy Clinical-Grade AI To Support Cancer Diagnostics 3/19/2026

    Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the United States.

  4. Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test In Multiple Markets In Asia With Manulife Partnership 3/16/2026

    Guardant Health, Inc. a leading precision oncology company, today announced the launch of the Shield multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in Asia.

  5. RevnaBio Secures Triple International Laboratory Accreditation To Expand Precision Medicine And Clinical Research Infrastructure In Africa 3/16/2026

    RevnaBio today announced that it has received triple accreditation from the American Association for Laboratory Accreditation (A2LA), validating its laboratory and biobanking operations under three internationally recognized standards: ISO 15189 for medical laboratories, ISO 20387 for biobanking, and ISO/IEC 17043 for proficiency testing providers.

  6. Genomic Testing Cooperative Opens Houston Laboratory, Expanding National Precision Oncology Network 3/12/2026

    Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS) solutions for hematologic neoplasm, solid tumors and liquid biopsy applications, today announced the opening of a new laboratory in Houston, Texas, expanding its national testing network.

  7. Inocras And NDS Partner To Deliver Clinical-Scale Whole-Genome Cancer Analytics In The Cloud 3/12/2026

    Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced a strategic partnership with NDS Corporation (NDS), a South Korean IT services provider specialized in healthcare data and cloud solutions.

  8. Eurofins Biomnis Launches New Clinical LC MS/MS Method For The Detection Of Cereulide Toxin In Stool Samples 3/11/2026

    Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples.

  9. C2N Diagnostics Enters South Korean Market Through Partnership With BeauBrain Healthcare To Offer Precivity Portfolio Of Blood Tests To Help Doctors Diagnose Alzheimer's Disease 3/11/2026

    C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation, has reached an agreement with BeauBrain Healthcare that brings its breakthrough diagnostic testing for Alzheimer’s disease to South Korea.

  10. QIAGEN Receives U.S. Clearance For Gastrointestinal Panels On Fully Automated QIAstat-Dx Rise Syndromic Testing System 3/10/2026

    QIAGEN N.V. today announced that the U.S. Food and Drug Administration (FDA) has cleared the use of all QIAstat-Dx Gastrointestinal (GI) Panels on the QIAstat-Dx Rise automated syndromic testing system.